Cargando…
Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma
The challenge of effectively delivering therapeutic agents to the brain has created an entire field of active research devoted to overcoming the blood brain barrier (BBB) and efficiently delivering drugs to the brain. Angiopep-2 can trigger transcytosis and traverse the BBB by recognizing low-densit...
Autores principales: | Li, Ying, Zheng, Xuemin, Gong, Min, Zhang, Jianning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346723/ https://www.ncbi.nlm.nih.gov/pubmed/27765902 http://dx.doi.org/10.18632/oncotarget.12708 |
Ejemplares similares
-
Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
por: Luo, Huilong, et al.
Publicado: (2020) -
Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas
por: Gould, Andrew, et al.
Publicado: (2021) -
Peptide Shuttles for Blood–Brain Barrier Drug Delivery
por: Sánchez-Navarro, Macarena, et al.
Publicado: (2022) -
Conjugation of a Blood Brain Barrier Peptide Shuttle
to an Fc Domain for Brain Delivery of Therapeutic Biomolecules
por: Cavaco, Marco, et al.
Publicado: (2021) -
Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
por: Zhang, Fang, et al.
Publicado: (2015)